S-IF-2, S-IF-3
S (4 Methoxyphenyl) 3 methylsulfonyl 2 oxoimidazolidine 1 carbothioate
6
(S) 2 (Methoxydiphenylmethyl) 1 (thiophen 3 ylmethyl)pyrrolidine
7
(S) 1 (2 Ammonio 3 methylbutyl) 1,2 dihydropyridin 2 iminium dibromide
8
(S) 4 [2 (3 Cyanobenzamido) 3 hydroxypropyl]phenyl 3 cyanobenzoate
8
(S) 3 Acetyl 3 [(R) 1 (4 bromophenyl) 2 nitroethyl]oxolan 2 one
7
(S) 2 (1H Imidazol 1 yl) 3 phenylpropanol
6
(S) 2 [(S) 2 Acetamido 3 phenylpropanamido] 3 phenylpropanoic acid
7
S p Tolyl 3 methanesulfonyl 2 oxoimidazolidine 1 carbothioate
6
(S) Methyl 2 benzamido 3 (3,4 dimethoxyphenyl)propanoate
9
μ Ferrio bis{carbonyl[μ 2,2′,2′′ nitrilotriethanethiolato(3 ) N,S,S′,S′′:S,S′]iron(II)} benzene solvate
10
(3RS) S [1 (3 Chlorophenyl) 2 oxopyrrolidin 3 yl]thiouronium bromide
9
(S) 2 (2 Chloroquinolin 3 yl) 2 [(S) α methylbenzylamino]acetonitrile
11
Methyl 2(S) (N fluoren 9 ylmethoxycarbonylamino) 3 (2 pyridyl)propionate
9
tert Butyl N [(S) 3 isopropyl 2 oxooxetan 3 yl]carbamate
9
1. Report No. 2. Government Accession No. 3. Recipient s Catalog No.
47
Chang e-3 s Progress and Achievement 2/2014
27
(S) Benzyl 2 amino 3 (4 hydroxyphenyl)propanoate
7
(S) Methyl 2 (4,5 dibromo 1H pyrrole 2 carboxamido) 3 methylbutanoate
8
(S) 2 (3 Nitrophenyl) 1,2 dihydroquinazolin 4(3H) one
7
K. Lashkaripour 1, N.M, Bakhshani *2, S. Mafi 3
8